Aliasullutide - igisubizo muri PBS / dulaglutide
URUBANZA No.923950-08-7
Isosiyete No: GT-F002
Urukurikirane: H-His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Glu-Gln-Ala-Ala-Lys-Glu-Phe-Ile- Ala-Trp-Leu-Val-Lys-Gly-Gl y-Gly-OH
Inzira ya molekulari: C149H221N37O49
Uburemere bwa molekuline: 3314.62
Dulaglutide CAS OYA.923950-08-7.jpg
Ibipimo bya tekiniki:
Kugaragara Ifu yera
Isuku (HPLC) yari ≥95.0%
Uburinganire bumwe butari munsi ya 2.0%
Acide acike yari hagati ya 5.0% na 12.0%
Ibirungo byari ≤10.0%
Ibirimo peptide byari ≥80.0%
Gupakira no kohereza:
Ubushyuhe buke, gupakira vacuum, neza kuri miligarama ubisabwe.
Ibisobanuro ku bicuruzwa:
Durraglutide nigishya gishya gikora GLP-1R agonist, gikomoka muguhuza ibice bibiri bya DPP-4 bibuza GLP-1 hamwe na immunoglobuline yumuntu uringaniye IgG4-Fc.Ibikorwa byayo bisa nkibya endogenous GLP-1 mubigaragaza kwa clinique, hamwe nubuzima bwigice cyiminsi 5, kandi birashobora gutinza neza impyiko.FDA yemeye dulaglutide yo gutera inshinge muri Nzeri 2014. Komisiyo y’Uburayi yemeje dulaglutide yo gutera inshinge mu Burayi mu Kuboza 2014.
Ububiko: Gukonjesha byumye kuri -20 ℃ bikabikwa kure yumucyo
Icyitonderwa: Kubigamije ubushakashatsi gusa, ntabwo ari kubintu byabantu
Igihe cyo kohereza: Ukwakira-13-2023